mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: A meta-analysis

van Sijl AM et al. – TNF-alpha blocking therapy has a modest effect on TC and HDLc levels in RA patients with no significant overall effect on the atherogenic index. Whether TNF-alpha blocking effects on qualitative lipid changes (structure and function) are more relevant to their presumed vascular benefits requires further study.

Methods

  • Literature searched to identify studies assessing changes in TC, HDL, LDL, triglycerides, atherogenic index (ie, TC/HDL ratio), and apolipoprotein levels in response to TNF-alpha blocking therapy
  • Weighted mean levels of lipids at different time points and subsequent changes in these lipid levels between these time points calculated with multivariate linear mixed models

Results

  • Data available on TC in 15 studies encompassing 766 RA patients and on HDLc in 14 studies encompassing 736 RA patients
  • TC increased significantly (maximum increase of 10%) and HDLc increased significantly in the first 2 to 6 weeks of therapy (maximum increase of 7%), after which it remained more or less stable
  • Atherogenic index did not significantly change over time
  • There was too limited information to evaluate changes in other lipids and apolipoproteins
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close